GRAIL, Inc. (GRAL) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $54.34 (-0.27%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 10, 2026 | Bradley Bowers | Mizuho Securities | $58.00 | +6.7% |
| Feb 24, 2026 | Kallum Titchmarsh | Morgan Stanley | $60.00 | +10.4% |
| Feb 20, 2026 | Catherine Ramsey Schulte | Robert W. Baird | $82.00 | +50.9% |
| Nov 12, 2025 | Subbu Nambi | Guggenheim | $100.00 | +84.0% |
| Oct 22, 2025 | Kyle Mikson | Canaccord Genuity | $85.00 | +56.4% |
Top Analysts Covering GRAL
GRAL vs Sector & Market
| Metric | GRAL | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.25 | 2.24 | 2.41 |
| Analyst Count | 8 | 8 | 18 |
| Target Upside | +42.3% | +1150.2% | +14.9% |
| P/E Ratio | -5.21 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $43M | $44M | $46M | 3 |
| 2026-09-30 | $44M | $45M | $47M | 1 |
| 2026-12-31 | $172M | $180M | $185M | 6 |
| 2027-03-31 | $44M | $46M | $48M | 3 |
| 2027-06-30 | $51M | $53M | $55M | 2 |
| 2027-09-30 | $53M | $55M | $58M | 2 |
| 2027-12-31 | $62M | $65M | $67M | 3 |
| 2028-03-31 | $56M | $58M | $61M | 2 |
| 2028-06-30 | $61M | $64M | $67M | 1 |
| 2028-09-30 | $64M | $67M | $70M | 1 |
| 2028-12-31 | $73M | $75M | $79M | 2 |
| 2029-12-31 | $341M | $370M | $400M | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-2.78 | $-2.67 | $-2.60 | 2 |
| 2026-09-30 | $-2.91 | $-2.79 | $-2.72 | 1 |
| 2026-12-31 | $-11.53 | $-11.08 | $-10.62 | 4 |
| 2027-03-31 | $-2.84 | $-2.69 | $-2.55 | 1 |
| 2027-06-30 | $-2.87 | $-2.72 | $-2.58 | 1 |
| 2027-09-30 | $-2.87 | $-2.71 | $-2.58 | 1 |
| 2027-12-31 | $-2.96 | $-2.80 | $-2.66 | 1 |
| 2028-03-31 | $-2.87 | $-2.71 | $-2.57 | 1 |
| 2028-06-30 | $-2.72 | $-2.57 | $-2.44 | 1 |
| 2028-09-30 | $-2.56 | $-2.42 | $-2.30 | 1 |
| 2028-12-31 | $-2.58 | $-2.44 | $-2.32 | 1 |
| 2029-12-31 | $-10.79 | $-9.77 | $-8.79 | 4 |
Frequently Asked Questions
What is the analyst consensus for GRAL?
The consensus among 8 analysts covering GRAIL, Inc. (GRAL) is Buy with an average price target of $85.40.
What is the highest price target for GRAL?
The highest price target for GRAL is $100.00, set by Subbu Nambi at Guggenheim on 2025-11-12.
What is the lowest price target for GRAL?
The lowest price target for GRAL is $58.00, set by Bradley Bowers at Mizuho Securities on 2026-04-10.
How many analysts cover GRAL?
8 analysts have issued ratings for GRAIL, Inc. in the past 12 months.
Is GRAL a buy or sell right now?
Based on 8 analyst ratings, GRAL has a consensus rating of Buy (2.25/5) with a +42.3% upside to the consensus target of $85.40.
What are the earnings estimates for GRAL?
Analysts estimate GRAL will report EPS of $-2.67 for the period ending 2026-06-30, with revenue estimated at $44M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.